|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JH, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 World Health Organization
Classification of Lung Tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ettinger DS, Akerley W, Bepler G, Blum MG,
Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, et
al: Non-small cell lung cancer. J Natl Compr Canc Netw. 8:740–801.
2010.PubMed/NCBI
|
|
5
|
Antoine M, Wirz W, Tag CG, Mavituna M,
Emans N, Korff T, Stoldt V, Gressner AM and Kiefer P: Expression
pattern of fibroblast growth factors (FGFs), their receptors and
antagonists in primary endothelial cells and vascular smooth muscle
cells. Growth Factors. 23:87–95. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu MC, Qiu WR, Wang YP, Hill D, Ring BD,
Scully S, Bolon B, DeRose M, Luethy R, Simonet WS, et al: FGF-18, a
novel member of the fibroblast growth factor family, stimulates
hepatic and intestinal proliferation. Mol Cell Biol. 18:6063–6074.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Canalis E, McCarthy TL and Centrella M:
Growth factors and cytokines in bone cell metabolism. Annu Rev Med.
42:17–24. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Z, Xu J, Colvin JS and Ornitz DM:
Coordination of chondrogenesis and osteogenesis by fibroblast
growth factor 18. Genes Dev. 16:859–869. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dailey L, Ambrosetti D, Mansukhani A and
Basilico C: Mechanisms underlying differential responses to FGF
signaling. Cytokine Growth Factor Rev. 16:233–247. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Turner N and Grose R: Fibroblast growth
factor signalling: From development to cancer. Nat Rev Cancer.
10:116–129. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Beenken A and Mohammadi M: The FGF family:
Biology, pathophysiology and therapy. Nat Rev Drug Discov.
8:235–253. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Marie PJ: Fibroblast growth factor
signaling controlling osteoblast differentiation. Gene. 316:23–32.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moore EE, Bendele AM, Thompson DL, Littau
A, Waggie KS, Reardon B and Ellsworth JL: Fibroblast growth
factor-18 stimulates chondrogenesis and cartilage repair in a rat
model of injury-induced osteoarthritis. Osteoarthritis Cartilage.
13:623–631. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sonvilla G, Allerstorfer S, Stättner S,
Karner J, Klimpfinger M, Fischer H, Grasl-Kraupp B, Holzmann K,
Berger W, Wrba F, et al: FGF18 in colorectal tumour cells:
Autocrine and paracrine effects. Carcinogenesis. 29:15–24. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koneczny I, Schulenburg A, Hudec X,
Knöfler M, Holzmann K, Piazza G, Reynolds R, Valent P and Marian B:
Autocrine fibroblast growth factor 18 signaling mediates
Wnt-dependent stimulation of CD44-positive human colorectal adenoma
cells. Mol Carcinog. 54:789–799. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei W, Mok SC, Oliva E, Kim SH, Mohapatra
G and Birrer MJ: FGF18 as a prognostic and therapeutic biomarker in
ovarian cancer. J Clin Invest. 123:4435–4448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rubinfeld H and Seger R: The ERK cascade:
A prototype of MAPK signaling. Mol Biotechnol. 31:151–174. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krejci P, Prochazkova J, Bryja V, Kozubik
A and Wilcox WR: Molecular pathology of the fibroblast growth
factor family. Hum Mutat. 30:1245–1255. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song L, Huang Z, Chen Y, Li H, Jiang C and
Li X: High-efficiency production of bioactive recombinant human
fibroblast growth factor 18 in Escherichia coli and its effects on
hair follicle growth. Appl Microbiol Biotechnol. 98:695–704. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) methods. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Wei Z, Li H, Dang Q, Zhang Z, Wang
L, Gao W, Zhang P, Yang D, Liu J, et al: Clinicopathological
significance of fibroblast growth factor 1 in non-small cell lung
cancer. Hum Pathol. 46:1821–1828. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arai D, Hegab AE, Soejima K, Kuroda A,
Ishioka K, Yasuda H, Naoki K, Kagawa S, Hamamoto J, Yin Y, et al:
Characterization of the cell of origin and propagation potential of
the fibroblast growth factor 9-induced mouse model of lung
adenocarcinoma. J Pathol. 235:593–605. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shimokawa T, Furukawa Y, Sakai M, Li M,
Miwa N, Lin YM and Nakamura Y: Involvement of the FGF18 gene in
colorectal carcinogenesis, as a novel downstream target of the
beta-catenin/T-cell factor complex. Cancer Res. 63:6116–6120.
2003.PubMed/NCBI
|
|
24
|
Tang SW, Yang TC, Lin WC, Chang WH, Wang
CC, Lai MK and Lin JY: Nicotinamide N-methyltransferase induces
cellular invasion through activating matrix metalloproteinase-2
expression in clear cell renal cell carcinoma cells.
Carcinogenesis. 32:138–145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McCubrey JA, Steelman LS, Chappell WH,
Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M,
Tafuri A, et al: Roles of the Raf/MEK/ERK pathway in cell growth,
malignant transformation and drug resistance. Biochim Biophys Acta.
1773:1263–1284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun L, Zhang Q, Li Y, Tang N and Qiu X:
CCL21/CCR7 up-regulate vascular endothelial growth factor-D
expression via ERK pathway in human non-small cell lung cancer
cells. Int J Clin Exp Pathol. 8:15729–15738. 2015.PubMed/NCBI
|
|
27
|
Han Y, Luo Y, Wang Y, Chen Y, Li M and
Jiang Y: Hepatocyte growth factor increases the invasive potential
of PC-3 human prostate cancer cells via an ERK/MAPK and Zeb-1
signaling pathway. Oncol Lett. 11:753–759. 2016.PubMed/NCBI
|
|
28
|
Li L, Duan T, Wang X, Zhang RH, Zhang M,
Wang S, Wang F, Wu Y, Huang H and Kang T: KCTD12 Regulates
colorectal cancer cell stemness through the ERK pathway. Sci Rep.
6:204602016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xia ZX, Li ZX, Zhang M, Sun LM, Zhang QF
and Qiu XS: CARMA3 regulates the invasion, migration, and apoptosis
of non-small cell lung cancer cells by activating NF-κB and
suppressing the P38 MAPK signaling pathway. Exp Mol Pathol.
100:353–360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bai RX, Wang WP, Zhao PW and Li CB:
Ghrelin attenuates the growth of HO-8910 ovarian cancer cells
through the ERK pathway. Braz J Med Biol Res. 49(pii):
S0100-879X2016000300602. 2016.
|
|
31
|
Kim JH, Cho EB, Lee J, Jung O, Ryu BJ, Kim
SH, Cho JY, Ryou C and Lee SY: Corrigendum to <Emetine inhibits
migration and invasion of human non-small-cell lung cancer cells
via regulation of ERK and p38 signaling pathways>. Chem Biol
Interact. Nov 2–2015.(Epub ahead of print). doi:
10.1016/j.cbi.2015.10.023.
|
|
32
|
Zhang Y, Zhao J, Qiu L, Zhang P, Li J,
Yang D, Wei X, Han Y, Nie S and Sun Y: Co-expression of ILT4/HLA-G
in human non-small cell lung cancer correlates with poor prognosis
and ILT4-HLA-G interaction activates ERK signaling. Tumour Biol.
37:11187–11198. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang C, Shi J, Mao SY, Xu YS, Zhang D,
Feng LY, Zhang B, Yan YY, Wang SC, Pan JP, et al: Role of p38 MAPK
in enhanced human cancer cells killing by the combination of
aspirin and ABT-737. J Cell Mol Med. 19:408–417. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Zhao H, Wang Y, Lin Y, Tan Y,
Fang X and Zheng L: Non-small cell lung cancer invasion and
metastasis promoted by MMP-26. Mol Med Rep. 4:1201–1209.
2011.PubMed/NCBI
|
|
35
|
Ming SH, Sun TY, Xiao W and Xu XM: Matrix
metalloproteinases-2, −9 and tissue inhibitor of
metallo-proteinase-1 in lung cancer invasion and metastasis. Chin
Med J (Engl). 118:69–72. 2005.PubMed/NCBI
|
|
36
|
Zhao D, Lu Y, Yang C, Zhou X and Xu Z:
Activation of FGF receptor signaling promotes invasion of
non-small-cell lung cancer. Tumour Biol. 36:3637–3642. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu X, Yang L, Zheng Z, Li Z, Shi J, Li Y,
Han S, Gao J, Tang C, Su L, et al: Src promotes cutaneous wound
healing by regulating MMP-2 through the ERK pathway. Int J Mol Med.
37:639–648. 2016.PubMed/NCBI
|
|
38
|
Xia Y, Lian S, Khoi PN, Yoon HJ, Joo YE,
Chay KO, Kim KK and Do Jung Y: Chrysin inhibits tumor
promoter-induced MMP-9 expression by blocking AP-1 via suppression
of ERK and JNK pathways in gastric cancer cells. PLoS One.
10:e01240072015. View Article : Google Scholar : PubMed/NCBI
|
